CCM
PGEN icon

Coldstream Capital Management’s Precigen PGEN Stock Holding History

Coldstream Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-827
Closed -$1.23K – 2711
2025
Q1 		$1.23K Buy
+827
New +$1.3K ﹤0.01% 3129

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Coldstream Capital Management's PGEN Position: Q2 2025 in Review

Coldstream Capital Management sold out of Precigen (PGEN) in Q2 2025, closing a stake of 827 shares — an estimated $1.23K sold.

Coldstream Capital Management first reported a position in PGEN in Q1 2025 and held it in 1 quarter. The position peaked at $1.23K in Q1 2025. 147 funds tracked by Wall St. Rank hold PGEN as of Q2 2025.

  • Coldstream Capital Management reported no remaining Precigen position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 827 Precigen shares in Q2 2025, an estimated $1.23K.
  • Coldstream Capital Management first reported a position in Precigen in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's Precigen position peaked at $1.23K in Q1 2025.
  • 147 funds tracked by Wall St. Rank held Precigen as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.